Transition State Analysis for Human and Plasmodium falciparum Purine Nucleoside Phosphorylases

Biochemistry

Volumn 43, Issue 6, 2004, Pages 1458-1468

  Lewandowicz, Andrzej ^a   Schramm, Vern L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; CELLS; DISEASES; ENZYME INHIBITION; ENZYMES; ISOTOPES;

PURINE SALVAGE; TIGHT-BINDING INHIBITIORS;

BIOCHEMISTRY;

PURINE; PURINE NUCLEOSIDE PHOSPHORYLASE;

ARTICLE; CHEMICAL BOND; DISSOCIATION; ENZYME CONFORMATION; ENZYME MECHANISM; ENZYME STRUCTURE; KINETICS; LYMPHOCYTE PROLIFERATION; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; T LYMPHOCYTE; VIBRATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ARSENATES; CARBON RADIOISOTOPES; CATTLE; DEUTERIUM EXCHANGE MEASUREMENT; DEUTERIUM OXIDE; ELECTROSTATICS; HUMANS; INOSINE; ISOENZYMES; KINETICS; PLASMODIUM FALCIPARUM; PROTONS; PURINE-NUCLEOSIDE PHOSPHORYLASE; SOLVENTS; SURFACE PROPERTIES; TRITIUM;

PLASMODIUM FALCIPARUM;

EID: 1042299983     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0359123     Document Type: Article

References (48)

1. Krudsood, S., Buchachart, K., Chalermrut, K., Charusabha, C., Treeprasertsuk, S., Haoharn, O., Duangdee, C., and Looareesuwan, S. (2002) A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria, Southeast Asian J. Trop. Med. Public Health 33, 525-531.
2. Winstanley, P. A., Ward, S. A., and Snow, R. W. (2002) Clinical status and implications of antimalarial drug resistance, Microbes Infect. 4, 157-164.
3. Sherman, I. W. (1979) Biochemistry of Plasmodium (malarial parasites), Microbiol. Rev. 43, 453-495.
4. Subbayya, I. N., Ray, S. S., Balaram, P., and Balaram, H. (1997) Metabolic enzymes as potential drug targets in Plasmodium falciparum, Indian J. Med. Res. 106, 79-94.
5. Queen, S. A., Jagt, D. L., and Reyes, P. (1990) In vitro susceptibilities of Plasmodium falciparum to compounds which inhibit nucleotide metabolism, Antimicrob. Agents Chemother. 34, 1393-1398.
6. Kicska, G. A., Tyler, P. C., Evans, G. B., Furneaux, R. H., Kim, K., and Schramm, V. L. (2002) Transition state analogue inhibitors of purine nucleoside phosphorylase from Plasmodium falciparum, J. Biol. Chem. 277, 3219-3225.
7. Kicska, G. A., Tyler, P. C., Evans, G. B., Furneaux, R. H., Schramm, V. L., and Kim, K. (2003) Purine-less death in Plasmodium falciparum induced by Immucillin-H, a transition state analogue of purine nucleoside phosphorylase, J. Biol. Chem. 277, 3226-3231.
8. Kicska, G. A., Long, L., Horig, H., Fairchild, C., Tyler, P. C., Furneaux, R. H., Schramm, V. L., and Kaufman, H. L. (2001) Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes, Proc. Natl. Acad. Sci. U.S.A. 98, 4593-4598.
9. Banti, S., Miller, P. J., Parker, C. D., Ananth, S. L., Horn, L. L., Babu, Y. S., and Sandhu, J. S. (2002) Comparison of in vivo efficacy of BCX-1777 and cyclosporin in xenogeneic graft-vs.-host disease: the role of dGTP in antiproliferative action of BCX-1777, Int. Immunopharmacol. 2, 913-923.
10. Pugmire, M. J., and Ealick, S. E. (2002) Structural analyses reveal two distinct families of nucleoside phosphorylases, Biochem. J. 361, 1-25.
11. Schramm, V. L. (2002) Development of transition state analogues of purine nucleoside phosphorylase as anti-T-cell agents, Biochim. Biophys. Acta 1587, 107-117.
12. Datta, N. S., Shewach, D. S., Mitchell, B. S., and Fox, I. H. (1989) Kinetic properties and inhibition of human T lymphoblast deoxycytidine kinase, J. Biol. Chem. 264, 9359-9364.
13. Bzowska, A., Kulikowska, E., and Shugar, D. (2000) Purine nucleoside phosphorylase: properties, functions, and clinical aspects, Pharmacol. Ther. 88, 349-425.
14. Giblett, E. R., Ammann, A. J., Wara, D. W., Sandman, R., and Diamond, L. K. (1975) Nucleoside phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity, Lancet 1, 1010-1013.
15. Bantia, S., Ananth, S. L., Parker, C. D., Horn, L. L., and Upshaw, R. (2003) Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor BCX-1777, Int. Immunopharmacol. 3, 879-887.
16. Schramm, V. L. (2003) Enzymatic transition state poise and transition state analogues, Acc. Chem. Res. 36, 588-596.
17. Schramm, V. L. (1999) Enzymatic transition-state analysis and transition-state analogs, Methods Enzymol. 308, 301-355.
18. Schramm, V. L., Horenstein, B. A., and Kline, P. C. (1994) Transition state analysis and inhibitor design for enzymatic reactions, J. Biol. Chem. 269, 18259-18262.
19. Schramm, V. L. (2001) Transition state variation in enzymatic reactions, Curr. Opin. Chem. Biol. 5, 556-563.
20. Cook, P. F. (1991) Enzyme Mechanism from Isotope Effects, p 4, CRC Press, Boca Raton, FL.
21. Kline, P. C., and Schramm, V. L. (1993) Purine nucleoside phosphorylase. Catalytic mechanism and transition-state analysis of the arsenolysis reaction, Biochemistry 32, 13212-13219.
22. Kicska, G. A., Tyler, P. C., Evans, G. B., Furneaux, R. H., Shi, W., Fedorov, A., Lewandowicz, A., Cahill, S. M., Almo, S. C., and Schramm, V. L. (2002) Atomic dissection of the hydrogen bond network for transition-state analogue binding to purine nucleoside phosphorylase, Biochemistry 41, 14489-14498.
23. Lewandowicz, A., Shi, W., Evans, G. B., Tyler, P. T., Furneaux, R. H., Basso, L. A., Santos, D. S., Almo, S. C., and Schramm, V. L. (2003) Over-the-barrier transition state analogues and crystal structure with Mycobacterium tuberculosis purine nucleoside phosphorylase, Biochemistry 42, 6057-6066.
24. Lewandowicz, A., Tyler, P. C., Evans, G. B., Furneaux, R. H., and Schramm, V. L. (2003) Achieving the ultimate goal in transition state analogues for human purine nucleoside phosphorylase, J. Biol. Chem. 34, 31465-31468.
25. Chen, X.-Y., Berti, P. J., and Schramm, V. L. (2000) Ricin A-chain: Kinetic isotope effects and transition state structure with stem-loop RNA, J. Am. Chem. Soc. 122, 1609-1617.
26. McIvor, R. S., Goddar, J. M., Simones, C. C., and Martin, D. W., Jr. (1985) Expression of cDNA sequence encoding human purine nucleoside phosphorylase in rodent and human cells, Mol. Cell. Biol. 5, 1349-1357.
27. + with the Specific Incorporation of Atomic Labels, J. Am. Chem. Soc. 116, 6531-6536.
28. 3H kinetic isotope effects on acid-catalyzed glycosidic bond hydrolysis of AMP, dAMP, and inosine, J. Biol. Chem. 259, 9411-9417.
29. Miles, R. W., Tyler, P. C., Furneaux, R. H., Bagdassarian, C. K., and Schramm, V. L. (1998) One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase, Biochemistry 37, 8615-8621.
30. Rose, I. A. (1980) The isotope trapping method: desorption rates of productive E.S complexes, Methods Enzymol. 64, 47-59.
31. Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Zakrzewski, V. G., Montgomery, J. A., Jr., Stratmann, R. E., Burant, J. C., Dapprich, S., Millam, J. M., Daniels, A. D., Kudin, K. N., Strain, M. C., Farkas, O. J., Tomasi, B. V., Cossi, M., Cammi, R., Mennucci, B., Pomelli, C., Adamo, C., Clifford, S., Ochterski, J., Petersson, G. A., Ayala, P. Y., Cui, Q., Morokuma, K., Malick, D. K., Rabuck, A. D., Raghavachari, K., Foresman, J. B., Cioslowski, J., Ortiz, J. V., Stefanov, B. B., Liu, G., Liashenko, A., Piskorz, P., Komaromi, I., Gomperts, R., Martin, R. L., Fox, D. J., Keith, T., Al-Laham, M. A., Peng, C. Y., Nanayakkara, A., Gonzalez, C., Challacombe, M., Gill, P. M. W., Johnson, B., Chen, W., Wong, M. W., Andres, J. L., Gonzalez, C., Head-Gordon, M., Replogle, E. S., and Pople, J. A. (1998) Gaussian 98, revision A.9, Gaussian, Pittsburgh, PA.
32. Becke, D. A. (1996) Density-functional thermochemistry. IV. A new dynamical correlation functional and implications for exact-exchange mixing, J. Chem. Phys. 104, 1040-1046.
33. Anisimov, V., and Paneth, P. (1999) ISOEFF98. A program for studies of isotope effects using Hessian modifications, J. Math. Chem. 26, 75-86.
34. Melander, L., and Saunders, W. H., Jr. (1980) Reaction Rates of Isotopic Molecules, Wiley and Sons, New York.
35. Flükiger, P., Lüthi, H. P., Portmann, S., and Weber, J. (2000) MOLEKEL 4.0, Swiss Center for Scientific Computing, Manno, Switzerland.
36. Bagdassarian, C. K., Shramm, V. L., and Schwartz, S. D. (1996) Molecular electrostatic potential analysis for substrates, competitive inhibitors and transition state inhibitors, Biochemistry 37, 8825-8836.
37. Parkin, D. W. (1991) in Enzyme Mechanismfrom Isotope Effects (Cook, P. F., Ed.) pp 269-290, CRC Press, Boca Raton, FL.
38. Horenstein, B. A., Parkin, D. W., Estupinan, B., and Schramm, V. L. (1991) Transition-state analysis of nucleoside hydrolase from Crithidia fasciculata, Biochemistry 30, 10788-10795.
39. Berti, P. J., and Tanaka, K. S. E. (2002) Transition state analysis using multiple kinetic isotope effects: mechanism of enzymatic and non-enzymatic glycoside hydrolysis and transfer, Adv. Phys. Org. Chem. 37, 239-314.
40. Chen, X.-Y., Berti, P. J., and Schramm, V. L. (2000) Transition state analysis for depurination of DNA by ricin A-chain, J. Am. Chem. Soc. 122, 6527-6534.
41. N2 transition states, J. Am. Chem. Soc. 119, 3670-3676.
42. Glad, S. S., and Jensen, F. (1997) Transition state looseness and β-secondary kinetic isotope effects, J. Am. Chem. Soc. 119, 227-232.
43. N1 substrate, J. Org. Chem. 68, 5399-5402.
44. N2 transition states, J. Am. Chem. Soc. 116, 2526-2533.
45. Sunko, D. E., Szele, I., and Hehre, W. J. (1977) Hyperconjugation and the angular dependence of beta-deuterium isotope effects, J. Am. Chem. Soc. 99, 5000-5005.
46. Swain, C. G., Stivers, E. C., Reuver, J. F., Jr., and Schaad, L. J. (1958) Use of hydrogen isotope effect to identify the attacking nucleophile in the enolization of ketones catalyzed by acetic acid, J. Am. Chem. Soc. 80, 5885-5893.
47. Evans, G. B., Furneaux, R. H., Lewandowicz, A., Schramm, V. L., and Tyler, P. C. (2003) Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase, J. Med. Chem. 46, 3412-3423.
48. Kresge, A. J., Lichtin, N. N., Rao, K. N., and Weston, R. E. (1965) The primary carbon isotope effect on the ionization of triphenylmethyl chloride. Experimental determination, theoretical justification, and implications for carbon isotope effects on nucleophilic substitution at saturated carbon, J. Am. Chem. Soc. 87, 437-445.